Biblio Discovery — Demo Discovery Service

7 hasil untuk "Sumit Deswal"

Menampilkan 1–7 · 0,24 detik · RSS

  1. Artikel Jurnal

    Models of T cell antigen receptor activation: the puzzle still remained

    Sumit Deswal

    Nepal Journal of Biotechnology, Vol. 2 No. 1 · 2012 · Inggris · DOAJ

    T cell antigen receptor (TCR) is a protein-complex expressed on all T cells of the immune system and is responsible for the activation of T cells when infectious agent is presented by an antigen presenting cell (APC) in the form of peptides bound to the major histocompatibility complex (pMHC)…

  2. Artikel Jurnal Teks lengkap

    Quantitative Analysis of Protein Phosphorylations and Interactions by Multi-Colour IP-FCM as an Input for Kinetic Modelling of Signalling Networks

    Sumit Deswal; Anna K. Schulze; Thomas Höfer dkk.

    PLoS ONE, Vol. 6 No. 7 · 2011 · Inggris · PLOS Scopus

    Background: To understand complex biological signalling mechanisms, mathematical modelling of signal transduction pathways has been applied successfully in last few years. However, precise quantitative measurements of signal transduction events such as activation-dependent phosphorylation of…

    Juga tersedia di: DOAJ

  3. Artikel Jurnal

    BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1

    Simon J. Hogg; Stephin J. Vervoort; Sumit Deswal dkk.

    Cell Reports, Vol. 18 No. 9 · 2017 · Inggris · DOAJ Scopus

    Summary: BET inhibitors (BETi) target bromodomain-containing proteins and are currently being evaluated as anti-cancer agents. We find that maximal therapeutic effects of BETi in a Myc-driven B cell lymphoma model required an intact host immune system. Genome-wide analysis of the BETi-induced…

  4. Artikel Jurnal

    Apelin inhibition prevents resistance and metastasis associated with anti‐angiogenic therapy

    Iris Uribesalgo; David Hoffmann; Yin Zhang dkk.

    EMBO Molecular Medicine, Vol. 11 No. 8 · 2019 · Inggris · DOAJ Scopus

    Abstract Angiogenesis is a hallmark of cancer, promoting growth and metastasis. Anti‐angiogenic treatment has limited efficacy due to therapy‐induced blood vessel alterations, often followed by local hypoxia, tumor adaptation, progression, and metastasis. It is therefore paramount to overcome…